No abstract available
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
-
Amides / pharmacology
-
Animals
-
Apoptosis / drug effects*
-
Cardiotonic Agents / pharmacology*
-
Cardiotonic Agents / therapeutic use
-
Coronary Circulation / drug effects
-
Enzyme Activation
-
Humans
-
Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
-
Intracellular Signaling Peptides and Proteins / metabolism*
-
Myocardial Infarction / metabolism
-
Myocardial Infarction / pathology
-
Myocardial Infarction / physiopathology
-
Myocardial Infarction / prevention & control*
-
Myocardial Reperfusion Injury / metabolism
-
Myocardial Reperfusion Injury / pathology
-
Myocardial Reperfusion Injury / physiopathology
-
Myocardial Reperfusion Injury / prevention & control*
-
Myocardium / enzymology
-
Myocardium / metabolism*
-
Myocardium / pathology
-
Nitric Oxide / metabolism
-
Nitric Oxide Synthase Type III / metabolism
-
Phosphatidylinositol 3-Kinases / metabolism
-
Protein Kinase Inhibitors / pharmacology*
-
Protein Kinase Inhibitors / therapeutic use
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / metabolism*
-
Proto-Oncogene Proteins c-akt / metabolism
-
Pyridines / pharmacology
-
Research Design
-
Signal Transduction / drug effects*
-
rho-Associated Kinases
Substances
-
Amides
-
Cardiotonic Agents
-
Intracellular Signaling Peptides and Proteins
-
Protein Kinase Inhibitors
-
Pyridines
-
Y 27632
-
Nitric Oxide
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
-
Nitric Oxide Synthase Type III
-
Protein Serine-Threonine Kinases
-
Proto-Oncogene Proteins c-akt
-
rho-Associated Kinases
-
fasudil